Peptides for Hair Growth & Follicle Health

Topical vs Systemic Application: Unlike many peptides used systemically, hair growth peptides like GHK-Cu are often applied topically directly to the scalp. This allows for targeted delivery to hair follicles while potentially minimising systemic effects. Formulation (serums, microneedling protocols) significantly affects penetration and efficacy.

GHK-Cu vs Minoxidil: While minoxidil is an FDA-approved hair loss treatment, GHK-Cu works through different mechanisms. Some research suggests they may be complementary, with GHK-Cu supporting the scalp environment while minoxidil promotes vasodilation. However, direct comparison studies are limited.

Peptide research for hair growth represents an emerging area with promising preclinical findings but limited clinical validation. GHK-Cu stands out as the most researched compound, with evidence supporting its role in follicle stimulation, angiogenesis promotion, and extracellular matrix remodelling.

Other peptides like Thymosin Beta-4 show intriguing stem cell activation properties, while BPC-157's angiogenic effects may support scalp health. However, it's crucial to maintain realistic expectations about what peptides can achieve for hair loss.

Key Takeaways: - No peptides are approved for hair loss treatment - GHK-Cu has the most supportive research for topical hair applications - Results typically require 3-6+ months to become apparent - Peptides are unlikely to reverse established baldness - Combining peptides with proven treatments (minoxidil, finasteride) requires medical guidance

For those experiencing hair loss, consulting a dermatologist or trichologist for evidence-based treatments remains the recommended first step. Peptide use, if considered, should be approached as experimental and with appropriate caution.

*Always consult accredited suppliers and qualified healthcare professionals in your jurisdiction.*